Search Within

James Joseph Harding

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (32)
  2. Journal Article (31)
Groups
  1. Biostatistics Service (63)
  2. Department of Medicine (63)
  3. Epidemiology and Biostatistics (63)
  4. Gastrointestinal Oncology Service (63)
  5. Solid Tumor Oncology Division (63)
  6. Center for Pancreatic Cancer Research (56)

More Groups

People
  1. Ghassan Abou-Alfa (48)
  2. Marinela Capanu (36)
  3. Eileen O'Reilly (35)
  4. Joanne Chou (29)
  5. William Jarnagin (26)
  6. Imane El Dika (18)

More People

Years
  1. 2025 (4)
  2. 2024 (8)
  3. 2023 (5)
  4. 2022 (3)
  5. 2021 (4)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. Cancer (5)
  3. Clinical Cancer Research (4)
  4. The Oncologist (4)
  5. Annals of Surgical Oncology (3)
  6. JCO Precision Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (31)
  2. Wiley Blackwell (7)
  3. Oxford University Press (6)
  4. American Association for Cancer Research (4)
  5. Springer (4)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (63)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab (NIVO) and drug eluting bead transarterial chemoembolization (deb-TACE): Preliminary results from a phase I study of patients (pts) with liver limited hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Yarmohammadi, H.; Reiss, K. A.; Chou, J. F.; Capanu, M.; Do, R. K. G.; Khalil, D.; El Dika, I. H.; Giardina, J. D.; Merghoub, T.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Embolization with microspheres alone for hepatocellular carcinoma with portal vein tumor: Analysis of outcome and liver function at disease progression
    Journal Article

    Borgheresi, A.; Covey, A.; Yarmohammadi, H.; Boas, F. E.; Ziv, E.; Getrajdman, G.; Erinjeri, J.; Jarnagin, W.; Harding, J. J.; D'Angelica, M.; more...
    HPB (2020)

    Fulltext@MSK | Save
  • Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: A phase 2 clinical trial
    Journal Article

    Cercek, A.; Boerner, T.; Tan, B. R.; Chou, J. F.; Gönen, M.; Boucher, T. M.; Hauser, H. F.; Do, R. K. G.; Lowery, M. A.; Harding, J. J.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes
    Journal Article

    Lowery, M. A.; Goff, L. W.; Keenan, B. P.; Jordan, E.; Wang, R.; Bocobo, A. G.; Chou, J. F.; O’Reilly, E. M.; Harding, J. J.; Kemeny, N.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Evolution of surgical management of gallbladder carcinoma and impact on outcome: Results from two decades at a single-institution
    Journal Article

    Creasy, J. M.; Goldman, D. A.; Gonen, M.; Dudeja, V.; O'Reilly, E. M.; Abou-Alfa, G. K.; Cercek, A.; Harding, J. J.; Balachandran, V. P.; Drebin, J. A.; more...
    HPB (2019)

    Fulltext@MSK | Save
  • In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
    Journal Article

    Khalil, D. N.; Suek, N.; Campesato, L. F.; Budhu, S.; Redmond, D.; Samstein, R. M.; Krishna, C.; Panageas, K. S.; Capanu, M.; Houghton, S.; more...
    Journal of Clinical Investigation (2019)

    Fulltext@MSK | Save
  • Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations
    Journal Article

    Narayan, R. R.; Creasy, J. M.; Goldman, D. A.; Gönen, M.; Kandoth, C.; Kundra, R.; Solit, D. B.; Askan, G.; Klimstra, D. S.; Basturk, O.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Binimetinib plus gemcitabine and cisplatin phase I/II trial in patients with advanced biliary cancers
    Journal Article

    Lowery, M. A.; Bradley, M.; Chou, J. F.; Capanu, M.; Gerst, S.; Harding, J. J.; El Dika, I.; Berger, M.; Zehir, A.; Ptashkin, R.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase 1B study of enzalutamide (ENZA) with or without sorafenib (SORA) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Kelley, R. K.; Tan, B. R.; Iobst, E.; Boussayoud, C.; Muenkel, K. E.; Do, R. K. G.; Chou, J. F.; Capanu, M.; Ruiz, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multicenter pilot study of nivolumab (NIVO) with drug eluting bead transarterial chemoembolization (deb-TACE) in patients (pts) with liver limited hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Erinjeri, J. P.; Tan, B. R.; Reiss, K. A.; Mody, K.; Khalil, D.; Yarmohammadi, H.; Nadolski, G.; Giardina, J. D.; Capanu, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save